Cadaverine Tartrate

Cadaverine Tartrate

SCHEMBL7337182

CCO.O.O=C(O)C(O)C(O)C(=O)O

nearest known ligand 0.62

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3CHRM1CHRM2CHRM3CHRM4ESR1ESR2GABRA1GABRB1GABRG2GBA1HRH1HTR1DHTR2AOPRD1OPRK1OPRM1SLC6A2SLC6A3TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8rplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Cadaverine Tartrate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM1 known ✓ P11229 1/20 0.39
CHRM3 known ✓ P20309 1/20 0.39
HTR2A known ✓ P28223 1/20 0.39
ADRA1A known ✓ P35348 1/20 0.39
HRH1 known ✓ P35367 1/20 0.39
SLC6A3 known ✓ Q01959 1/20 0.39
GBA1 known ✓ P04062 1/20 0.36
TSHR P16473 4/20 0.62
OR51E2 Q9H255 1/20 0.50
CYP2C9 P11712 1/20 0.46
PDE4A P27815 1/20 0.46
TP53 P04637 1/20 0.42
AKR1A1 P14550 1/20 0.39
HTR2C P28335 1/20 0.39
DRD3 P35462 1/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC2 Q92769 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
NFKB1 P19838 1/20 0.38
CYP2C19 P33261 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cadaverine Tartrate SCHEMBL282045 0.97 TSHR (0.67) TSHROR51E2CYP2C9PDE4ATP53
Tartaric Acid SCHEMBL30771976 0.97 TSHR (0.67) TSHROR51E2CYP2C9PDE4ATP53
Cadaverine Tartrate SCHEMBL27681736 0.94 TSHR (0.62) TSHROR51E2CYP2C9PDE4ATP53
Cadaverine Tartrate SCHEMBL27981116 0.94 TSHR (0.62) TSHROR51E2CYP2C9PDE4ATP53
Cadaverine Tartrate SCHEMBL27681738 0.94 TSHR (0.62) TSHROR51E2CYP2C9PDE4ATP53
Cadaverine Tartrate SCHEMBL6560274 0.91 TSHR (0.59) TSHROR51E2CYP2C9PDE4ATP53
Cadaverine Tartrate SCHEMBL18987140 0.87 TSHR (0.71) TSHROR51E2CYP2C9PDE4ATP53
Cadaverine Tartrate SCHEMBL27525534 0.84 TSHR (0.67) TSHROR51E2CYP2C9PDE4ATP53
Cadaverine Tartrate SCHEMBL2158124 0.84 TSHR (0.67) TSHRCYP2C9PDE4ATP53CHRM1
Cadaverine Tartrate SCHEMBL905466 0.83 TSHR (0.91) TSHROR51E2CYP2C9PDE4ATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0741724-B1 NEUROPROTECTIVE CHROMAN COMPOUNDS PFIZER (US) 1999-08-11 EP claimed
EP-0741724-A1 NEUROPROTECTIVE CHROMAN COMPOUNDS PFIZER INC. (US) 1996-11-13 EP disclosed
WO-1995020587-A1 NEUROPROTECTIVE CHROMAN COMPOUNDS PFIZER INC. (US) 1995-08-03 WO disclosed